Studies
-
Status: Archived
Risk factors for default in a large MDR TB treatment programme in Uzbekistan amongst patients commencing treatment from 2003 until 2008
Archived by: 'System'
-
Status: Study was withdrawn or postponed
Treatment outcomes in Multi Drug Resistance TB patients in Uzbekistan
Principal investigator: Philipp du CrosLatest update: Principal investigator changed | 8th October 2016
-
Status: Archived
Analysis of the Management of Isoniazid Resistant Pulmonary TB in Karakalpakstan, Uzbekistan 2003-2010
Archived by: Holly Baker | 26th July 2022
-
Status: Archived
What determines Tuberculous Meningitis(TBM) treatment outcomes in a resource limited settings: retrospective review from MSF programmes in 9 countries
Archived by: Holly Baker | 26th July 2022
-
Status: Study was withdrawn or postponed
Risk factors associated with adverse TB outcomes: a multi-centric retrospective cohort study
Study details: Observational studyPrincipal investigator: Philipp du CrosLatest update: Principal investigator changed | 9th October 2016
-
Status: Study was withdrawn or postponed
Determinants of extra-pulmonary TB presentation and outcomes: a multi-country retrospective cohort study
Study details: Observational studyPrincipal investigator: Philipp du CrosLatest update: Principal investigator changed | 9th October 2016
-
Status: Archived
Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan
Archived by: 'System'
-
Status: Archived
Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central Asia
Archived by: Holly Baker | 26th July 2022
-
Status: Archived
Comparison of initiation of drug sensitive and drug resistant TB treatment in hospital versus ambulatory setting: outcomes and factors affecting outcomes
Archived by: 'System'
-
Status: Archived
Optimising the use of control interventions for cholera and malaria in humanitarian emergencies
Archived by: Holly Baker | 4th August 2022
-
Status: Archived
Multi-centric analysis of drug-resistant tuberculosis patients treated with Delamanid (Dlm) in MSF projects site: a short communication
Archived by: Holly Baker | 10th August 2022
-
Status: Completion
Treatment Outcomes of Multi-drug resistant TB (MDR-TB) treatment: shorter MDR TB treatment regimen compared with standard of care in Uzbekistan
-
Status: Archived
Association between bedaquiline use and QT interval: a cohort analysis of data from a drug-resistant tuberculosis programme in Chechnya and Uzbekistan
Archived by: 'System'